Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
2.13Prev. Close
2.08Volume
3,254Total traded value
0.00 CrUpper Circuit
2.18Lower Circuit
1.98Fundamentals
| Market Cap | ₹8.32Cr |
| ROE | -17.01% |
| P/E Ratio(TTM) | -9.90 |
| EPS(TTM) | -0.21 |
| P/B Ratio | 2.10 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.23 |
| Book Value | 0.99 |
| Debt to Equity | 2.18 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Vivanza Biosciences
Vivanza Biosciences is a leading Indian pharmaceutical company dedicated to providing high-quality medicines and healthcare solutions through research, development, and manufacturing. The company's primary mission is to contribute to a healthier society by improving the lives of people on a global scale. It demonstrated steady performance by earning a standalone revenue of ₹14.46 crores during the financial year 2023-24.;
| Parent Organisation | Vivanza Biosciences Limited |
| Managing Director | Mr. Jayendra Mehta |
| BSE Symbol | 530057 |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 104.59 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.64 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 34.18 | ||
| Wockhardt | NA (0.00%) | -201.57 |